Skip to main content
Log in

99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

99mTc-glucarate is an infarct-avid imaging agent. However, patients may have mixtures of normal, irreversibly injured, stunned, and hibernating myocardium. The purposes were to determine 99mTc-glucarate uptake and clearance kinetics in these four conditions, and its ability to determine the extent of injury.

Methods

Twenty-two perfused rat hearts were studied: controls (n = 5), stunned (n = 5; 20-min no-flow followed by 5-min reflow), hibernating (n = 6; 120-min low flow at 4 ml/min), and ischemic-reperfused (n = 6; 120-min no-flow followed by reflow). 99mTc-glucarate was then infused. Tracer activity was monitored using a NaI scintillation detector and a multichannel analyzer. Creatine kinase, electron microscopy, and triphenyltetrazolium chloride determined viability.

Results

99mTc-glucarate 10-min myocardial uptake was significantly greater in ischemic-reperfused (2.50 ± 0.09) (cpm, SEM) than in control (1.74 ± 0.07), stunned (1.68 ± 0.11), and hibernating (1.59 ± 0.11) (p < 0.05). Tracer retention curves for ischemic-reperfused were elevated at all time points as compared with the other groups. 99mTc-glucarate 60-min myocardial uptake was significantly greater in ischemic-reperfused (7.60 ± 0.63) than in control (1.98 ± 0.15), stunned (1.79 ± 0.08), and hibernating (2.33 ± 0.15) (p < 0.05). The 60-min well-counted tracer activity ratio of ischemic-reperfused to control was 9:1 and corroborated the NaI detector results. Creatine kinase, triphenyltetrazolium chloride, and electron microscopy all demonstrated significantly greater injury in ischemic-reperfused compared to the other groups. An excellent correlation was observed between viability markers and tracer activity (r = 0.99 triphenyltetrazolium chloride; r = 0.90 creatine kinase).

Conclusion

99mTc-glucarate activity continually and progressively increased in irreversibly injured myocardium. 99mTc-glucarate uptake was strongly correlated with myocardial necrosis as determined by three independent assessments of viability. There were minimal and similar 99mTc-glucarate uptakes in control, stunned, and hibernating myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Beanlands RS, Ruddy TD, Bielawski L, Johansen H. Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics. J Nucl Cardiol 1997;4:274–82.

    Article  CAS  PubMed  Google Scholar 

  2. Khaw BA, Nakazawa A, O’Donnell SM, Pak KY, Narula J. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997;4:283–90.

    Article  CAS  PubMed  Google Scholar 

  3. Mariani G, Villa G, Rossettin PF, Spallarossa P, Bezante GP, Brunelli C, et al. Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. J Nucl Med 1999;40:1832–9.

    CAS  PubMed  Google Scholar 

  4. Ohtani H, Callahan RJ, Khaw BA, Fishman AJ, Wilkinson RA, Strauss HW. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. J Nucl Med 1992;33:1988–93.

    CAS  PubMed  Google Scholar 

  5. Okada DR, Johnson G, Liu Z, Hocherman SD, Khaw BA, Okada RD. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate. J Nucl Med 2004;45:655–64.

    CAS  PubMed  Google Scholar 

  6. Johnson 3rd G, Okada CC, Hocherman SD, Liu Z, Hart C, Khaw BA, et al. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. Eur J Nucl Med Mol Imaging 2006;33:319–28.

    Article  PubMed  Google Scholar 

  7. Johnson LL, Schofield L, Mastrofrancesco P, Donahay T, Farb A, Khaw BA. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. J Nucl Cardiol 2000;7:590–8.

    Article  CAS  PubMed  Google Scholar 

  8. Narula J, Petrov A, Pak KY, Lister BC, Khaw BA. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. Circulation 1997;95:1577–84.

    CAS  PubMed  Google Scholar 

  9. Chopra P, Sabherwal U. Histochemical and fluorescent techniques for detection of early myocardial ischemia following experimental coronary artery occlusion: a comparative and quantitative study. Angiology 1988;39:132–40.

    Article  CAS  PubMed  Google Scholar 

  10. Ford WR, Clanachan AS, Hiley CR, Jugdutt BI. Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts. Br J Pharmacol 2001;134:38–45.

    Article  CAS  PubMed  Google Scholar 

  11. Rammohan RPA, Haider N, Vural I, Pak CKY, Narula J, Khaw BA. Subnuclear localization of Tc-99m glucarate in necrotic myocardium. J Nucl Med 1996;37:175P.

    Google Scholar 

  12. Khaw BA, Rammohan R. Tc-99m glucaric acid targets the nucleoproteins of acutely necrotic myocardium but cannot target myocardial cell death due to apoptosis. Circulation 1999;100:I-310.

    Google Scholar 

  13. Okada DR, Johnson 3rd G, Liu Z, Hocherman SD, Khaw BA, Pak KY, et al. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. J Nucl Cardiol 2003;10:168–76.

    Article  CAS  PubMed  Google Scholar 

  14. Orlandi C, Crane PD, Edwards DS, Platts SH, Bernard L, Lazewatsky J, et al. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med 1991;32:263–8.

    CAS  PubMed  Google Scholar 

  15. Yaoita H, Fischman AJ, Wilkinson R, Khaw BA, Juweid M, Strauss HW. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. J Nucl Med 1993;34:1303–8.

    CAS  PubMed  Google Scholar 

  16. Liu Z, Barrett HH, Stevenson GD, Kastis GA, Bettan M, Furenlid LR, et al. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. J Nucl Med 2004;45:1251–9.

    PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported in part by grants from the American Heart Association, the William K. Warren Medical Research Institute, and the Anne and Henry Zarrow Foundation. This study is dedicated to the William K. Warren family and the Anne and Henry Zarrow family for their support of medical research, without which these experiments would not have been possible. We are indebted to William Meek Ph.D. for his help in the presentation of the EM data.

Conflicts of interest

Ban-An Khaw is a shareholder in Molecular Targeting Technologies, Inc. The other authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert D. Okada.

Additional information

This work was supported by the American Heart Association, the Anne and Henry Zarrow Foundation, and the William K. Warren Medical Research Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okada, D.R., Liu, Z., Johnson, G. et al. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model. Eur J Nucl Med Mol Imaging 37, 1909–1917 (2010). https://doi.org/10.1007/s00259-010-1495-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-010-1495-0

Keywords

Navigation